Clinical Validation

Test your assumptions with the people who will need to adopt the product.

TAUR structures product-specific input from relevant German clinicians and KOLs to validate clinical need, workflow fit, adoption barriers and reference-centre potential before major launch decisions are made.

TAUR Expert Panel

Structured German clinical and market validation.

Structured German clinical and market validation for MedTech companies preparing market entry, launch or expansion. TAUR assembles product-specific input from the relevant German clinicians and KOLs — not a simple survey — to inform a commercial decision.

The Expert Panel is TAUR's structured German clinical expert-validation capability. It is not an official EU regulatory expert panel.

See how clinical validation fits into MedTech market entry in Germany.

Clinical Adoption

Validate clinical need and whether German clinicians will actually use the product.

Workflow Fit

Test how the product fits existing German clinical workflows and pathways.

Adoption Barriers

Identify the structural and behavioural barriers that could slow adoption.

Reference Centres

Assess reference-centre potential and where clinical advocates could emerge.

Market Access

Pressure-test reimbursement and access assumptions with the German context in mind.

Commercial Relevance

Confirm the commercial relevance of the product for German buyers and payers.

From Adoption to Evidence

Generate evidence where the product is actually used.

When German adoption requires structured real-world evidence or PMCF operations, TAUR can coordinate clinical sites, physician onboarding, workflows, structured data capture and programme reporting.

TAUR is an operational evidence-generation partner for German clinical settings — not a generic CRO. Evidence is a later-stage capability that follows clinical validation.

Clinical sites

Coordinate the German sites where adoption and evidence meet.

Physician onboarding

Onboard clinicians into structured workflows and data capture.

Real-world evidence

Design RWE programmes that support reimbursement and adoption.

PMCF operations

Run post-market clinical follow-up with structured reporting.

Next step

Validate your German clinical assumptions before you commit.